Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: Implications for in vivo coinfection with HTLV-I and HIV-1

Journal of Experimental Medicine

Volumn 187, Issue 10, 1998, Pages 1689-1697

  Moriuchi, Hiroyuki ^a   Moriuchi, Masako ^a,b   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HOWARD UNIVERSITY   (United States)

Author keywords

Chemokine receptors; Chemokines; HIV; HTLV I; Tax

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TAX PROTEIN;

ARTICLE; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CHEMOKINES; GENE PRODUCTS, TAX; HIV INFECTIONS; HIV-1; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; RECEPTORS, CHEMOKINE; VIRUS REPLICATION;

EID: 0032543232     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.10.1689     Document Type: Article

References (57)

1. Connor, R.I., and D.D. Ho. 1994. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:4400-4408.
2. Connor, R.I., W.A. Paxton, K.E. Sheridan, and R.A. Koup. 1996. Macrophages and CD4+ lymphocytes from two multiply exposed, uninfected individuals resist infection with primary nonsyncytium-inducing isolates of human immunodeficiency virus type 1. J. Virol. 70:8758-8764.
3. Connor, R.I., K.E. Sheridan, C. Ceradini, S. Choe, and N.R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185:621-628.
4. Zhu, T., H. Mo, N. Wang, D.S. Nam, Y. Cao, R.A. Koup, and D.D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 261:1179-1181.
5. Gendelman, H.E., W. Phelps, L. Feigenbaum, J.M. Ostrove, A. Adachi, P.M. Howley, G. Khoury, H.S. Ginsberg, and M.A. Martin. 1986. Transactivation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc. Natl. Acad. Sci. USA. 83:9759-9763.
6. Scala, G., I. Quinto, M.R. Ruocco, M. Mallardo, C. Ambrosino, B. Squitieri, P. Tassone, and S. Venuta. 1993. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 67:2853-2861.
7. Siekevitz, M., S.F. Josephs, M. Dukovich, N. Peffer, F. Wong-Staal, and W.C. Greene. 1987. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science. 238:1575-1578.
8. Boehnlein, E., M. Siekevitz, D.W. Ballard, J.W. Lowenthal, L. Rimsky, H. Bogerd, J. Hoffman, Y. Wano, B.R. Franza, and W.C. Greene. 1988. Stimulation of the HIV-1 enhancer by the HTLV-I tax gene product involves the action of inducible cellular proteins. J. Virol. 63:1578-1586.
9. Pleskoff, O., C. Treboute, A. Brelot, N. Heveker, M. Seman, and M. Alizon. 1997. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science. 276:1874-1878.
10. Bartholomew, C., W.A. Blattner, and F. Cleghorn. 1987. Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet. 2:1469.
11. Page, J.B., S.H. Lai, D.D. Chitwood, N.G. Klimas, P.C. Smith, and M.A. Fletcher. 1990. HTLV-I/II positivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet. 335:1439-1441.
12. Pagliuca, A., and G.J. Mufti. 1990. Co-infection with HTLV-I/II and HIV-1. Lancet. 336:383.
13. Cleghorn, F.R., and W.A. Blattner. 1992. Does human T cell lymphotropic virus type I and human immunodeficiency virus type 1 coinfection accelerate acquired immunodeficiency syndrome? Arch. Intern. Med. 152:1372-1373.
14. Gotuzzo, E., J. Escamilla, I.A. Phillips, J. Sanchez, F.S. Wignall, and J. Antigoni. 1992. The impact of human T-lymphotropic virus type I/II infection on the prognosis of sexually acquired cases of acquired immunodeficiency syndrome. Arch. Intern. Med. 152:1429-1432.
15. Schechter, M., L.H. Harrison, N.A. Halsey, G. Trade, M. Santino, L.H. Moulton, and T.C. Quinn. 1994. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA (J. Am. Med. Assoc.). 271:353-357.
16. Fantry, L., E. Dodging, P.G. Auwaerter, and H.M. Lederman. 1995. Immunodeficiency and elevated CD4 lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type I. Clin. Infect. Dis. 21:1446-1448.
17. Harrison, L.H., T.C. Quinn, and M. Schechter. 1997. Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo. J. Infect. Dis. 175:438-440.
18. Harada, S., Y. Koyanagi, and N. Yamamoto. 1985. Infection of HTLV-III/LAV in HTLV-I-carrying cells. Science. 229:563-566.
19. Popovic, M., G. Lange-Wantzin, P.S. Sarin, D. Mann, and R.C. Gallo. 1983. Transformation of human umbilical cord blood T cells by human T cell leukemia/lymphoma virus. Proc. Natl. Acad. Sci. USA. 80:5402-5406.
20. tax protein in the human T-cell line, Jurkat. J. Virol. 68:3220-3226.
21. Ohtani, K., M. Nakamura, S. Saito, K. Nagata, K. Sugamura, and Y. Hinuma. 1989. Electroporation: application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemic virus type I. Nucleic Acids Res. 17:1589-1604.
22. + T-cell-derived factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc. Natl. Acad. Sci. USA. 93:15341-15345.
23. Jeang, K.-T., S.G. Widen, O.J. Semmes, and S.H. Wilson. 1990. HTLV-I trans-activator protein, Tax, is a trans-repressor of the human β-polymerase gene. Science. 247:1082-1084.
24. Moriuchi, H., M. Moriuchi, and J.I. Cohen. 1995. Proteins and cis acting elements associated with transactivation of the varicella-zoster virus (VZV) immediate-early gene 62 promoter by VZV open reading frame 10 protein. J. Virol. 69:4693-4701.
25. Zack, J.A., A.J. Cann, J.P. Lugo, and I.S.Y. Chen. 1988. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science. 240:1026-1029.
26. Adachi, A., H.E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M.A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
27. Collman, R., J.W. Balliet, S.A. Gregory, H. Friedman, D.L. Kolson, N. Nathanson, and A. Srinivasan. 1992. An infectious molecular clone of unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66:7517-7521.
28. Theodore, T.S., G. Englund, A. Buckler-White, C.E. Buckler, M.A. Martin, and K.W. Peden. 1996. Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions. AIDS Res. Hum. Retroviruses. 12:191-194.
29. Poli, G., A.L. Kinter, and A.S. Fauci. 1994. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA. 91:108-112.
30. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, et al. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1135-1148.
31. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:661-666.
32. Feng, Y., C.C. Broder, P.E. Kennedy, and E.A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:872-877.
33. Moriuchi, H., M. Moriuchi, J. Arthos, J. Hoxie, and A.S. Fauci. 1997. Promonocytic U937 clones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion with T-tropic HIV-1. J. Virol. 71:9664-9671.
34. Chosa, T.N., Y. Yamamoto, Y. Tanaka, Y. Koyanagi, and Y. Hinuma. 1982. Infectivity dissociated from transforming activity in a human retrovirus adult T-cell leukemia virus. Gann. 73:844-847.
35. Miyoshi, I., H. Taguchi, M. Fujishita, S. Yoshimoto, I. Kubonishi, Y. Ohtsuki, Y. Shiraishi, and T. Akagi. 1982. Transformation of monkey lymphocytes with adult T-cell leukemia virus. Lancet. 2:658.
36. Clapham, P., K. Nagy, R. Cheingsong-Popov, and R.A. Weiss. 1983. Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science. 222:1125-1127.
37. 1 protein. New Biol. 2:1034-1043.
38. 1 protein stimulates proliferation of human peripheral blood lymphocytes. New Biol. 3:678-686.
39. Dhib-Jalbut, S., P.M. Hoffman, T. Yamabe, D. Sun, J. Xia, H. Eisenberg, G. Berger, and F.W. Ruscetti. 1994. Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells. Ann. Neurol. 36:787-790.
40. Hollsberg, P, and D. A. Hafler. 1993. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1173-1182.
41. + T cells. Science. 270:1811-1815.
42. Baba, M., T. Imai, T. Yoshida, and O. Yoshie. 1996. Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type I: role of the viral transactivator Tax. Int. Cancer. 66:124-129.
43. Himes, S.R., R. Katsikeros, and M.F. Shannon. 1996. Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type I trans activator Tax. J. Virol. 70:4001-4008.
44. Bacon, K.B., B.A. Premack, P. Gardner, and T.J. Schall, 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science. 269:1727-1730.
45. Taub, D.D., J.R. Ortaldo, S.M. Turcovski-Corrales, M.L. Key, D.L. Longo, and W.J. Murphy. 1996. β chemokines costimulate lymphocyte cytolysis, proliferation, and lyphokine production. J. Leukocyte Biol. 59:81-89.
46. Taub, D.D., T.J. Sayers, C.R.D. Carter, and J.R. Ortaldo. 1995. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877-3888.
47. Taub, D.D., S.M. Turcovski-Corrales, M.L. Key, D.L. Longo, and W.J. Murphy. 1996. Chemokines and T lymphocyte activation. I. β chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156:2095-2103.
48. Turner, L., S.G. Ward, and J. Westwick. 1995. RANTES-activated human T lymphocytes. A role for phosphomositide 3-kinase. J. Immunol. 155:2437-2444.
49. Szabo, M.C., E.C. Butcher, B.W. McIntyre, T.J. Schall, and K.B. Bacon. 1997. RANTES stimulation of T lymphocyte adhesion and activation: role for LFA-1 and ICAM-3. Eur. J. Immunol. 27:1061-1068.
50. Springer, T. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: multistep paradigm. Cell. 76:301-314.
51. Smith, M.R., and W.C. Greene. 1991. Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia. J. Clin. Invest. 87:761-766.
52. Franchini, G. 1995. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood. 86:3619-3639.
53. Moriuchi, H., M. Moriuchi, and A.S. Fauci. 1997. Cloning and analysis of the promoter region for CCR5, a co-receptor for HIV-1 entry. J. Immunol. 159:5441-5449.
54. Moriuchi, M., H. Moriuchi, W. Turner, and A.S. Fauci. 1997. Cloning and analysis of the promoter region for CXCR4, a co-receptor for HIV-1 entry. J. Immunol. 159:4322-4329.
55. Chang-Mayer, C., D. Seto, M. Tateno, and J.A. Levy. 1988. Biological features of HIV-1 that correlate with virulence in the host. Science. 240:80-82.
56. Schuitemaker, H., M. Koot, N.A. Kootstra, M.W. Dercksen, R.E. de Goede, R.P. van Steenwijk, J.M. Lange, J.K. Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354-1360.
57. Tersmette, M., R.E. de Goede, B.J. Al, I.N. Winkel, R.A. Gruters, H.T. Cuypers, H.G. Huisman, and F. Miedema. 1988. Differential syncytium-mducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.